CIDP invited to speak at the 6th anti-ageing Skin Care Conference


Alternativ











Mauritius, 01 June 2017
CIDP Centre International de Développement Pharmaceutique, a Mauritius-based private and independent Contract Research Organisation (CRO), today announces its participation in the next Anti-Ageing Skin Care Conference which will take place between 5-6 June at 30 Euston Square, London.

 

At the conference, CIDP will be presenting its new topic about anti-pollution: Cutaneous Ageing due to Environmental Pollutants. Jessen Curpen, Biophysics Manager and Responsible of the Development of Clinical Study Designs, will share more about CIDP’s innovative study protocol for substantiating anti-pollution claims made on cosmetic products.

 

CIDP is a pioneer international group that specialises in research and development activities for cosmetics, pharmaceutical, medical device, and nutrition, industries. With more than 15 years of experience, CIDP is a leading company in the field offering extensive scientific expertise in the dermo-cosmetics sector.

 

Having served the personal care market for nearly two decades, CIDP is familiar with manufacturers’ research needs and well-versed with the techniques required,” said Mrs Claire Blazy-Jauzac, CEO of CIDP. “We’re excited to introduce the results of our new set of standard methodologies to address the rising popularity of anti-pollution claims at the Anti-Ageing Skin Care Conference this year.”

 

Air pollution is considered as the second most important cause of extrinsic cutaneous ageing. Today, a growing number of cosmetics manufacturers are developing products that aim to protect the skin from the harmful effect of air-pollution. However, the challenge for substantiating an anti-pollution claim remains the lack of standardized protocols for this type of efficacy testing.

 

CIDP’s presentation will shed light on the salient features of a standardized protocol for antipollution claims substantiation while illustrating the setting up of its unique Controlled Pollution Exposure System that can expose human subjects to controlled concentration and flux of pollutants such as ambient dust or ozone.

 

The 2-day conference is established as a high-level forum for in-depth presentations and discussions on the scientific, regulatory and marketing issues affecting this highly relevant and rapidly developing anti-ageing skin care sector.


For more information, please visit www.cidp-cro.com.


About Centre International de Développement Pharmaceutique (CIDP)
CIDP is a private and independent Contract Research Organisation (CRO) that conducts high-performing research and clinical activities for cosmetics, pharmaceutical and nutrition industries. The group serves clients with its full suite of services - comprising in vitro and ex vivo testing, analytical chemistry, formulation, and clinical research. Established in 2004, CIDP is a leading company in the field offering extensive scientific expertise in the dermo-cosmetics sector.

Earlier in 2017, CIDP unveiled its innovative study protocol for substantiating anti-pollution and blue light claims on cosmetic products. Since then, and recognized for its innovative researches, the company has developed an ex vivo model as an addition to its in vivo protocols. This new ex vivo model allows experiments to be conducted in conditions close to the in vivo model.

The geographical locations of CIDP's centres - in Mauritius, Brazil, India, Romania and Singapore - enable the company the access to a wide panel of patients. This allows the group to undertake multi-centric trials with a rapid recruitment process in a secured and adapted environment. Recognised for its expertise, CIDP works with the leaders of the cosmetics and pharmaceutical industry.

Having served the personal care market for nearly two decades, CIDP is familiar with manufacturers' research needs and well-versed with the techniques required. Our Preclinical Laboratory is GLP certified. CIDP is ISO 9001:2015 certified and GCP compliant.

« back